Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Buccal Tablets Titration for Breakthrough Cancer Pain
NCT00842829Phase 4Terminated
- Sponsor
- Cephalon, Inc.
- Start
- Jan 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in breakthrough cancer pain (BTcP), sponsored by Cephalon, Inc.. Started Jan 2009; status: terminated.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT00842829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842829.